v3.26.1
Condensed Consolidated Statements of Stockholders’ Equity (unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated Other comprehensive loss
Accumulated deficit
Beginning balance (in shares) at Sep. 30, 2024   58,877      
Beginning balance at Sep. 30, 2024 $ 472,689 $ 0 $ 1,715,119 $ (522) $ (1,241,908)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Restricted common stock canceled (in shares)   (137)      
Vesting of restricted stock units (in shares)   1,038      
Exercise of stock options (in shares)   331      
Exercise of stock options 5,551   5,551    
Issuance of shares under the employee stock purchase plan (in shares)   65      
Issuance of shares under the employee stock purchase plan 2,429   2,429    
Repurchases of common stock for income tax withholding (14)   (14)    
Stock-based compensation 48,417   48,417    
Other comprehensive loss (342)     (342)  
Net income (loss) (50,532)       (50,532)
Ending balance (in shares) at Jun. 30, 2025   60,174      
Ending balance at Jun. 30, 2025 478,198 $ 0 1,771,502 (864) (1,292,440)
Beginning balance (in shares) at Mar. 31, 2025   59,857      
Beginning balance at Mar. 31, 2025 440,108 $ 0 1,753,600 (662) (1,312,830)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Vesting of restricted stock units (in shares)   227      
Exercise of stock options (in shares)   90      
Exercise of stock options 1,829   1,829    
Repurchases of common stock for income tax withholding (3)   (3)    
Stock-based compensation 16,076   16,076    
Other comprehensive loss (202)     (202)  
Net income (loss) 20,390       20,390
Ending balance (in shares) at Jun. 30, 2025   60,174      
Ending balance at Jun. 30, 2025 $ 478,198 $ 0 1,771,502 (864) (1,292,440)
Beginning balance (in shares) at Sep. 30, 2025 60,632 60,632      
Beginning balance at Sep. 30, 2025 $ 472,958 $ 0 1,793,163 (627) (1,319,578)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for investment in equity securities (in shares)   275      
Issuance of common stock for investment in equity securities 13,750   13,750    
Issuance of common stock in connection with asset acquisition (in shares)   201      
Issuance of common stock in connection with asset acquisition $ 10,000   10,000    
Vesting of restricted stock units (in shares)   1,192      
Exercise of stock options (in shares) 270 270      
Exercise of stock options $ 5,882   5,882    
Issuance of shares under the employee stock purchase plan (in shares)   104      
Issuance of shares under the employee stock purchase plan 2,358 $ 1 2,357    
Repurchases of common stock for income tax withholding (16)   (16)    
Stock-based compensation 50,414   50,414    
Other comprehensive loss (28)     (28)  
Net income (loss) $ (109,579)       (109,579)
Ending balance (in shares) at Jun. 30, 2026 62,674 62,674      
Ending balance at Jun. 30, 2026 $ 445,739 $ 1 1,875,550 (655) (1,429,157)
Beginning balance (in shares) at Mar. 31, 2026   62,154      
Beginning balance at Mar. 31, 2026 455,094 $ 1 1,849,838 (639) (1,394,106)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock for investment in equity securities (in shares)   74      
Issuance of common stock for investment in equity securities 3,750   3,750    
Vesting of restricted stock units (in shares)   269      
Exercise of stock options (in shares)   177      
Exercise of stock options 3,793   3,793    
Repurchases of common stock for income tax withholding (7)   (7)    
Stock-based compensation 18,176   18,176    
Other comprehensive loss (16)     (16)  
Net income (loss) $ (35,051)       (35,051)
Ending balance (in shares) at Jun. 30, 2026 62,674 62,674      
Ending balance at Jun. 30, 2026 $ 445,739 $ 1 $ 1,875,550 $ (655) $ (1,429,157)